Finance

Results: 1189-1200 of 33778

PR Newswire associated0

A Scoop for Amsterdam: ARTIS Zoo officially recognized for protection of nocturnal darkness

Lone Star Announces Sale of Xella to Holcim

MOSS!MODULARITY Injection Screw

Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform and Announces Introduction of Multiple New Products

PR Newswire associated0

ENGWE Launches 'Explore a New Way' Tour, Connecting Riders Worldwide

Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report

Business Wire logo

Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma

Business Wire logo

Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment

PR Newswire associated0

China's Sichuan Extends Cultural Tourism Invitations at Global Landmarks

PR Newswire associated0

One Heung Kong released the White Paper on Global Sustainable and Healthy Living Environments jointly with other institutions

NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025

Business Wire logo

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025